Physician

Cristina Tita, M.D.

According to 2025 Medicare claims, Cristina Tita, M.D. (NPI: 1861605362) practices advanced heart failure and transplant cardiology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH SYSTEM (NPI: 1982787487; TIN: 38-1357020) and primary practice location at 48202-2608. Tita is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Tita's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 111 traditional Medicare patients, billed 394 HCPCS/CPT codes, and received $28,685 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,460 prescription claims across 246 beneficiaries totaling $809,515 in drug costs, led by Vyndaqel (Tafamidis Meglumine). DME data shows 157 claims. Open Payments data shows 5 records totaling $634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $69,946 to $28,685. In contrast, Part D prescription costs have moved sharply higher in recent years, from $228,874 to $809,515. For DME billing, this smaller-volume category fell sharply in recent years, from $4,688 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	214	959	$69,946
2016	203	907	$77,118
2017	201	847	$71,490
2018	194	681	$57,197
2019	194	656	$58,089
2020	157	488	$42,593
2021	162	654	$55,979
2022	122	401	$34,188
2023	130	383	$29,713
2024	111	394	$28,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	299	2,313	$228,874
2016	317	2,625	$183,248
2017	347	2,976	$240,761
2018	333	2,670	$223,175
2019	342	2,514	$227,763
2020	342	2,776	$522,482
2021	362	2,879	$596,892
2022	316	2,523	$638,523
2023	262	2,418	$794,016
2024	246	2,460	$809,515

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	50	196	$11,255
2016	65	558	$54,650
2017	50	642	$28,201
2018	41	322	$13,387
2019	49	293	$7,049
2020	37	515	$56,598
2021	40	438	$32,977
2022	32	361	$38,426
2023	N/R	206	$3,915
2024	N/R	157	$2,851

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	82	123	$112
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	16	42	$95
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	39	59	$13
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	13	15	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	12	12	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndaqel	Tafamidis Meglumine	12	360	$234,757
Jardiance	Empagliflozin	143	10,560	$192,903
Entresto	Sacubitril/Valsartan	106	6,997	$142,717
Eliquis	Apixaban	64	4,260	$77,938
Farxiga	Dapagliflozin Propanediol	16	1,307	$24,350

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	70	$1,517
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	55	$941
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	32	$393

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$634	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cristina Tita, M.D.?

Tedicare shows public-source Medicare data for Cristina Tita, M.D. (NPI 1861605362), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cristina Tita, M.D. have ACO affiliation data?

Cristina Tita, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Cristina Tita, M.D.?

Cristina Tita, M.D. is linked to HENRY FORD HEALTH SYSTEM (billing NPI 1982787487) in the available physician profile data.

Does Cristina Tita, M.D. have Open Payments data?

Cristina Tita, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.